Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
Title:
Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
Author:
Dave, Hema Terpilowski, Madeline Mai, Mimi Toner, Keri Grant, Melanie Stanojevic, Maja Lazarski, Christopher Shibli, Abeer Bien, Stephanie A. Maglo, Philip Hoq, Fahmida Schore, Reuven Glenn, Martha Hu, Boyu Hanley, Patrick J. Ambinder, Richard Bollard, Catherine M.